Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes

Author： Hara Naoko   Alkanani Aimon   Dinarello Charles   Zipris Danny  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.92, Iss.1, 2014-01, pp. : 93-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A novel histone deacetylase 6‐selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody‐induced arthritis mouse model

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 5, 2015-06 ,pp. : 514-523

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma Cells

By  

Oncology, Vol. 66, Iss. 6, 2004-09 ,pp. : 481-491

Karger

Access to resources Recommend Favorite

Histone deacetylase inhibitor for NUT midline carcinoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 715-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1223-1230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ‐26481585), by the Pediatric Preclinical Testing Program

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 245-252

John Wiley & Sons Inc

Access to resources Recommend Favorite